Literature DB >> 21660500

Clinical predictive values of extended-spectrum beta-lactamase carriage in patients admitted to medical wards.

E Ruppé1, A Pitsch, F Tubach, V de Lastours, F Chau, B Pasquet, J-C Lucet, A Andremont, B Fantin.   

Abstract

We aimed to reassess, through clinical items, populations at risk for extended-spectrum beta-lactamase-producing Enterobacteriaceae (ESBL-E) carriage at admission to hospital and to assess the risk of further positive clinical culture of ESBL-E among carriers. We performed a 5-month cohort study in a medicine ward of a 500-bed university teaching hospital in the Parisian area of France. All admitted patients were prospectively enrolled for rectal swabbing and clinical data collection, including bacterial infection at admission and during stay. Variables associated with ESBL-E carriage were identified by univariate and multivariate analysis. Five hundred patients were included. The prevalence of ESBL-E was 6.6% (33/500) upon admission. Only previous carriage of multidrug-resistant bacteria (MDRB) was associated with carriage (odds ratio [OR]: 17.7, 95% confidence interval (CI) 5.8-54.2, p < 0.001), yet, the positive predictive value (PPV) was not higher than 50%. When prior MDRB carriage was not considered in the multivariate analysis, only prior antibiotic consumption was found to be associated with carriage at admission (OR: 2.2 [1.1-4.5], p = 0.02). Two patients had ESBL-E infection at admission, yet, no patient became infected with ESBL-E during their stay. The clinical prediction of ESBL carriage at admission in our wards was found to be poorly efficient for assessing the at-risk population.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21660500     DOI: 10.1007/s10096-011-1313-z

Source DB:  PubMed          Journal:  Eur J Clin Microbiol Infect Dis        ISSN: 0934-9723            Impact factor:   3.267


  19 in total

1.  Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli.

Authors:  Jesús Rodríguez-Baño; Juan C Alcalá; Jose M Cisneros; Fabio Grill; Antonio Oliver; Juan P Horcajada; Teresa Tórtola; Beatriz Mirelis; Gemma Navarro; María Cuenca; María Esteve; Carmen Peña; Ana C Llanos; Rafael Cantón; Alvaro Pascual
Journal:  Arch Intern Med       Date:  2008-09-22

2.  Epidemiological typing of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae isolates responsible for five outbreaks in a university hospital.

Authors:  C Branger; B Bruneau; A L Lesimple; P J Bouvet; P Berry; J Sevali-Garcia; N Lambert-Zechovsky
Journal:  J Hosp Infect       Date:  1997-05       Impact factor: 3.926

3.  Transferable resistance to third-generation cephalosporins in clinical isolates of Klebsiella pneumoniae: identification of CTX-1, a novel beta-lactamase.

Authors:  D Sirot; J Sirot; R Labia; A Morand; P Courvalin; A Darfeuille-Michaud; R Perroux; R Cluzel
Journal:  J Antimicrob Chemother       Date:  1987-09       Impact factor: 5.790

4.  Surveillance of extended-spectrum beta-lactamases from clinical samples and faecal carriers in Barcelona, Spain.

Authors:  Elisenda Miró; Beatriz Mirelis; Ferran Navarro; Alba Rivera; Raúl Jesús Mesa; Ma Carme Roig; Laura Gómez; Pere Coll
Journal:  J Antimicrob Chemother       Date:  2005-10-21       Impact factor: 5.790

5.  Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens.

Authors:  H Knothe; P Shah; V Krcmery; M Antal; S Mitsuhashi
Journal:  Infection       Date:  1983 Nov-Dec       Impact factor: 3.553

6.  Population-based laboratory surveillance for Escherichia coli-producing extended-spectrum beta-lactamases: importance of community isolates with blaCTX-M genes.

Authors:  Johann D D Pitout; Nancy D Hanson; Deirdre L Church; Kevin B Laupland
Journal:  Clin Infect Dis       Date:  2004-05-25       Impact factor: 9.079

7.  Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital.

Authors:  R Ben-Ami; M J Schwaber; S Navon-Venezia; D Schwartz; M Giladi; I Chmelnitsky; A Leavitt; Y Carmeli
Journal:  Clin Infect Dis       Date:  2006-02-27       Impact factor: 9.079

8.  Molecular characteristics of travel-related extended-spectrum-beta-lactamase-producing Escherichia coli isolates from the Calgary Health Region.

Authors:  Johann D D Pitout; Lorraine Campbell; Deirdre L Church; Daniel B Gregson; Kevin B Laupland
Journal:  Antimicrob Agents Chemother       Date:  2009-04-13       Impact factor: 5.191

9.  Nursing homes as a reservoir of extended-spectrum beta-lactamase (ESBL)-producing ciprofloxacin-resistant Escherichia coli.

Authors:  Paul J Rooney; Maureen C O'Leary; Anne C Loughrey; Mark McCalmont; Brian Smyth; Philip Donaghy; Motasim Badri; Neil Woodford; Edi Karisik; David M Livermore
Journal:  J Antimicrob Chemother       Date:  2009-06-23       Impact factor: 5.790

10.  Prospective evaluation of colonization with extended-spectrum beta-lactamase (ESBL)-producing enterobacteriaceae among patients at hospital admission and of subsequent colonization with ESBL-producing enterobacteriaceae among patients during hospitalization.

Authors:  Reuven Friedmann; David Raveh; Esther Zartzer; Bernard Rudensky; Ellen Broide; Denise Attias; Amos M Yinnon
Journal:  Infect Control Hosp Epidemiol       Date:  2009-06       Impact factor: 3.254

View more
  11 in total

1.  Carriage of Enterobacteria Producing Extended-Spectrum β-Lactamases and Composition of the Gut Microbiota in an Amerindian Community.

Authors:  María José Gosalbes; Jorge F Vázquez-Castellanos; Cécile Angebault; Paul-Louis Woerther; Etienne Ruppé; María Loreto Ferrús; Amparo Latorre; Antoine Andremont; Andrés Moya
Journal:  Antimicrob Agents Chemother       Date:  2015-11-09       Impact factor: 5.191

Review 2.  Trends in human fecal carriage of extended-spectrum β-lactamases in the community: toward the globalization of CTX-M.

Authors:  Paul-Louis Woerther; Charles Burdet; Elisabeth Chachaty; Antoine Andremont
Journal:  Clin Microbiol Rev       Date:  2013-10       Impact factor: 26.132

3.  Extended spectrum beta-lactamase carriage state among elderly nursing home residents in Beirut.

Authors:  M A Jallad; R Naoufal; J Irani; E Azar
Journal:  ScientificWorldJournal       Date:  2015-03-18

Review 4.  More Pathogenicity or Just More Pathogens?-On the Interpretation Problem of Multiple Pathogen Detections with Diagnostic Multiplex Assays.

Authors:  Andreas E Zautner; Uwe Groß; Matthias F Emele; Ralf M Hagen; Hagen Frickmann
Journal:  Front Microbiol       Date:  2017-06-29       Impact factor: 5.640

5.  Transfer of a bla CTX-M-1-carrying plasmid between different Escherichia coli strains within the human gut explored by whole genome sequencing analyses.

Authors:  Per Kristian Knudsen; Karianne Wiger Gammelsrud; Kristian Alfsnes; Martin Steinbakk; Tore G Abrahamsen; Fredrik Müller; Jon Bohlin
Journal:  Sci Rep       Date:  2018-01-10       Impact factor: 4.379

6.  Local prevalence of extended-spectrum beta-lactamase (ESBL) producing Enterobacteriaceae intestinal carriers at admission and co-expression of ESBL and OXA-48 carbapenemase in Klebsiella pneumoniae: a prevalence survey in a Spanish University Hospital.

Authors:  Cristina Díaz-Agero Pérez; Nieves López-Fresneña; Angela L Rincon Carlavilla; Marta Hernandez Garcia; Patricia Ruiz-Garbajosa; Jesús María Aranaz-Andrés; Friederike Maechler; Petra Gastmeier; Marc J M Bonten; Rafael Canton
Journal:  BMJ Open       Date:  2019-03-01       Impact factor: 2.692

7.  Mechanisms of antimicrobial resistance in Gram-negative bacilli.

Authors:  Étienne Ruppé; Paul-Louis Woerther; François Barbier
Journal:  Ann Intensive Care       Date:  2015-08-12       Impact factor: 6.925

8.  Carriage of extended-spectrum beta-lactamase-producing enterobacteriacae among internal medicine patients in Switzerland.

Authors:  Janet Pasricha; Thibaud Koessler; Stephan Harbarth; Jacques Schrenzel; Véronique Camus; Gilles Cohen; Arnaud Perrier; Didier Pittet; Anne Iten
Journal:  Antimicrob Resist Infect Control       Date:  2013-06-12       Impact factor: 4.887

9.  Risk factors for infections with extended-spectrum beta-lactamase-producing Escherichia coli in a county of Southern Sweden.

Authors:  Johan Tham; Inga Odenholt; Mats Walder; Lina Andersson; Eva Melander
Journal:  Infect Drug Resist       Date:  2013-09-19       Impact factor: 4.003

10.  Extended-spectrum beta-lactamase--producing enterobacteriaceae in the intensive care unit: acquisition does not mean cross-transmission.

Authors:  Mikael Alves; Astrid Lemire; Dominique Decré; Dimitri Margetis; Naïke Bigé; Claire Pichereau; Hafid Ait-Oufella; Jean-Luc Baudel; Georges Offenstadt; Bertrand Guidet; Frédéric Barbut; Eric Maury
Journal:  BMC Infect Dis       Date:  2016-04-13       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.